RSS Content

Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference

BOULDER, Colo., Sept. 19, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Cantor Fitzgerald Global Healthcare Conference.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:                         

Cantor Fitzgerald Global Healthcare Conference

Presenter:                   

Ron Squarer, Chief Executive Officer

Date:                           

Tuesday, September 26, 2017

Time:                          

8:35 a.m. Eastern Time

Webcast:                     

http://wsw.com/webcast/cantor6/arry/

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).

CONTACT:      

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-cantor-fitzgerald-global-healthcare-conference-300520754.html

SOURCE Array BioPharma Inc.